• SmartestCrowd
    • No organizations
    • No projects
0
0
Aurobindo Pharma posts 12% slump in Q4 net profit at Rs 506 crore, revenue jumps 11% - Moneycontrol
5/27/23 at 5:11pm
Organization
Moneycontrol
Author
Moneycontrol News
45 words
0
Comments
The EBITDA came in at Rs 1,002 crore in Q4FY23, which is three percent higher as against Rs 974.4 crore recorded in the year-ago period.
10 similar articles
Q4 results roundup: BHEL's net profit falls 33%, City Union Bank's rises 4% - Economic Times
IRCTC Q4 results: Share price gains over 3% ahead of earnings | Mint - Mint
City Union Bank Q4 Result Review: Analysts Forecast Low Net Interest Margin - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
IRCTC Q4 Results: Profit Beats Estimates Despite Flat Ticket Sales - BQ Prime
You are the first to view
https://www.moneycontrol.com/news/business/earnings/aurobindo-pharma-posts-12-slump-in-q4-net-profit-at-rs-506-crore-revenue-jumps-11-10677291.html
Create an account or login to join the discussion